In 2012, using a combination of next generation sequencing and algorithms for predicting the binding of peptides to MHC class I and class II molecules, Castle and coworkers identified TSAs in B16-F10 mouse melanoma cells (Castle et al., 2012). The gene discussed is HLA-C; the disease is melanoma.